Global DNA Sequencing Technologies, Markets and Companies Report 2016 - Estimates to 2020 & 2025 - Research and Markets

DUBLIN, Dec 5, 2016 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report "DNA Sequencing - Technologies, Markets and Companies" to their offering.

This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.

Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2015 is described with estimates for 2020 and 2025. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.

The report includes profiles of 137 companies involved in sequencing and their 145 collaborations. The report text is supplementd by 42 tables, 21 figures and 500 selected references to the literature.

Key Topics Covered:

Executive Summary

1. Introduction

2. DNA Sequencing Technologies

3. Role of Bioinformatics in Sequencing

4. Comparative Analysis of Sequencing Technologies

5. Sequencing for Research

6. Applications of Sequencing in Healthcare

7. Applications of Sequencing in Oncology

8. Sequencing in Genetic Disorders

9. Sequencing in Neurological and Psychiatric Disorders

10. Applications of sequencings in infections

11. Role of Sequencing in Personalized Medicine

12. Current Status and Future Prospects

13. Markets for Sequencers

14. Companies Involved in Sequencing

15. References

For more information about this report visit http://www.researchandmarkets.com/research/n7b2fl/dna_sequencing

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716